Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Self-Driving EV and Tech (IDRV) vs Twist Bioscience Corp (TWST) Price & Performance

iShares Self-Driving EV and TechTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

iShares Self-Driving EV and Tech vs Twist Bioscience Corp — how do they compare? iShares Self-Driving EV and Tech trades at $33.26 (market cap $264.50M), while Twist Bioscience Corp trades at $161.11 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 38.1× iShares Self-Driving EV and Tech's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Self-Driving EV and Tech for 73 Days and Twist Bioscience Corp for 27 Days on average.

IDRVTWST
Market Cap
$264.50M$10.08B
Volume
48,0214,229,037
Sector
Sector/ThematicHealth
52-Week High
$45.48$205.00
52-Week Low
$32.68$25.45
Typical Hold Time
73 Days27 Days
Enterprise Value
—$10.01B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Self-Driving EV and Tech

No Aura AI signal available yet.

Twist Bioscience Corp

TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.

The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IDRV

No sentiment data available yet.

TWST
37% Buy63% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About iShares Self-Driving EV and Tech

IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.

Read more on IDRV →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →